HK Stock MarketDetailed Quotes

01875 TOT BIOPHARM-B

Watchlist
  • 1.890
  • -0.030-1.56%
Market Closed Sep 13 16:08 CST
1.46BMarket Cap145.38P/E (TTM)

TOT BIOPHARM-B Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

TOT BIOPHARM-B H1 FY2024 Earnings Date

Currency：CNYAug 13, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
--
520.60M
--
+58.69%
EPS
--
0.04
--
+303.11%
Analyst Rating
No Data

TOT BIOPHARM-B Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 1.377B--
--2024/FY-- / 1.094B--
Mar 24, 20222021/FY76.325M / 51.900M--
Mar 23, 20212020/FY22.491M / 53.213M--
Mar 17, 20202019/FY45.308M / 58.000M--
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 1.377B--
--2024/FY-- / 1.094B--
Mar 24, 20222021/FY76.325M / 51.900M--
Mar 23, 20212020/FY22.491M / 53.213M--
Mar 17, 20202019/FY45.308M / 58.000M--

Unlock Free Earnings Estimates

TOT BIOPHARM-B Earnings Reports

  • TOT BIOPHARM-B: INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2024

    Aug 13 09:58 ET

  • TOT BIOPHARM-B: DATE OF BOARD MEETING

    Aug 1 04:34 ET

  • TOT BIOPHARM-B: ANNUAL REPORT 2023

    Apr 26 06:01 ET

  • TOT BIOPHARM-B: ANNUAL RESULTS ANNOUNCEMENTFOR THE YEAR ENDED 31 DECEMBER 2023

    Mar 15 10:08 ET

    • Read more

    Analysis

    Analyst Rating

    No Data

    Price Target

    No Data

    Heat List
    HK
    Overall
    Symbol
    Latest Price
    % Chg

    No Data